Publications

2022
Mahnum Shahzad, Zirui Song, Michael E. Chernew, and A. M. Fendrick. 11/1/2022. “Changes in use of low-value services during the COVID-19 pandemic.” The American Journal of Managed Care, 28, 11, Pp. 600-604.
Richard G Frank, Mahnum Shahzad, and Ezekiel J Emanuel. 2022. “Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials: Study examines accelerated cancer drug trials.” Health Affairs, 41, 9, Pp. 1273–1280.
Richard G Frank, Mahnum Shahzad, Aaron S Kesselheim, and William Feldman. 2022. “Biosimilar competition: Early learning.” Health Economics, 31, 4, Pp. 647–663.
2021
Mahnum Shahzad, Huseyin Naci, and Anita K. Wagner. 2021. “Estimated Medicare spending on cancer drug indications with a confirmed lack of clinical benefit after US Food and Drug Administration accelerated approval.” JAMA Internal Medicine, 181, 12, Pp. 1673-1675. Publisher's Version